Skip to content

Psyence Biomedical Ltd.

PBM PBMWW

CIK 0001985062

← back to feed
Revenue (TTM)
—
Q2 Sep 2025
Net Income (TTM)
$1.01M
+102.0% YoY Q2 Sep 2025
EPS Diluted (TTM)
$5.24
+100.1% YoY Q2 Sep 2025
Gross Margin
—
Q2 Sep 2025
Operating Margin
—
Q2 Sep 2025
Net Margin
—
Q2 Sep 2025
Free Cash Flow (TTM)
—
Q2 Sep 2025
Cash
$7.15M
Q2 Sep 2025
Total Debt
—
Q2 Sep 2025
Shares Outstanding
568.02K sh
Q2 Sep 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings